Editor's Note Doctors are urging the American Medical Association (AMA) to take legal action or otherwise help recoup their losses from the February 21 Cyberattack on Change Healthcare, a division of United HealthGroup. Forbes reported the news June 3. The article cites a a resolution before the AMA’s reference committee on amendments…
Editor's Note Change Healthcare is responsible for notifying affected parties about privacy breaches resulting from the February cyberattack on the company, The U.S. Department of Health and Human Services (HHS) announced May 31. The announcement took the form of an update to an FAQ webpage from HHS’ Office for Civil…
Editor's Note Researchers claim a stem cell transplant cured type 2 diabetes in a 59-year-old man who previously needed multiple daily insulin injections, the South China Morning Post reported May 27. The Chinese researchers behind the reported breakthrough published details of the case April 30 in the journal Cell Discovery.…
Editor's Note The US Food and Drug Administration (FDA) has designated OptumHealth Care Solutions’ recall of the Nimbus II ambulatory infusion pumps a class 1, the most severe category indicating risk of serious injury or death. According to the agency’s May 30 announcement, the company recalled the pumps in direct…
Editor's Note Need for physical examination, technological limitations, care quality concerns, and malpractice risk topped the list of perceived barriers to employing video visits in surgical care in a study published May 10 in the journal Surgery. This study was reportedly the first to comprehensively survey surgeons on their perception…
Editor's Note Colorado is the first state in naton to pass legislation regulating the use of artificial intelligence (AI) in pivotal decision-making, including in healthcare, according to a May 22 report in Politico. The new law has sparked significant debate, according to the report, with some viewing it as a…
Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…
Editor's Note Artificial intelligence (AI) threatens patient safety by undermining the judgment of human nurses, according to a survey by National Nurses United (NNU). “The findings, coupled with anecdotal reports from nurses at hospitals nationwide, underscore the urgent need for stricter regulation and greater input from nurses and health care…
Editor's Note A choking hazard prompted the US Food and Drug Administration (FDA) to designate Vyaire Medical’s recall of Twin Tube sample lines—critical components of the Vyntus CPX system—as Class 1, the most serious category of recall indicating a risk of serious injury or death. According to the agency’s May…
More than 4 years after personal protective equipment production and inventories crashed amid the global COVID-19 pandemic, the “new normal” in healthcare supply chains seems to be “uncertainty.” Although hospital margins are improving and patient volumes are trending upward, “stress fractures continue to remain in place,” says Michael Schiller, CMRP,…